Standardized Hemorrhagic Shock Induction Guided by Cerebral Oximetry and Extended Hemodynamic Monitoring in Pigs
May 21st, 2019
7K views
Hemorrhagic shock is a severe complication in seriously injured patients, which leads to life-threatening oxygen undersupply. We present a standardized method to induce hemorrhagic shock via blood withdrawal in pigs that is guided by hemodynamics and microcirculatory cerebral oxygenation.
Overview
This article presents a standardized, reproducible porcine model for inducing life-threatening hemorrhagic shock through calculated blood withdrawal. The protocol utilizes near-infrared spectroscopy (NIRS) and advanced hemodynamic monitoring to titrate shock induction based on systemic and cerebral circulatory failure, closely simulating clinical scenarios of severe hemorrhagic shock.
Key Study Components
Area of Science
- Translational medicine
- Critical care research
- Experimental physiology
Background
- Hemorrhagic shock is a leading cause of death in severe trauma due to loss of blood volume and oxygen carriers.
- The brain is highly susceptible to hypoxic damage during shock due to limited compensatory mechanisms.
- Existing animal models often use predefined blood removal volumes, which may not accurately reflect clinical circulatory failure.
- Monitoring both macro- and microcirculatory parameters is crucial for realistic shock modeling.
Purpose of Study
- To establish a flexible and clinically relevant porcine model of hemorrhagic shock.
- To guide shock induction using real-time cerebral oximetry and hemodynamic monitoring.
- To enable evaluation of various therapeutic interventions for hemorrhagic shock.
Methods Used
- Ultrasound-guided cannulation of femoral artery and vein in anesthetized pigs.
- Insertion of arterial and central venous lines for blood withdrawal and monitoring.
- Continuous hemodynamic assessment using PiCCO system (pulse contour cardiac output).
- Real-time cerebral regional oxygenation monitoring via near-infrared spectroscopy sensors.
- Stepwise blood withdrawal titrated to hemodynamic and cerebral oxygenation targets.
Main Results
- Progressive blood removal leads to marked decreases in cerebral oxygen saturation, cardiac index, and arterial blood pressure.
- Indicators of shock include tachycardia, reduced intrathoracic blood volume, and increased stroke volume variation.
- Hemoglobin and hematocrit remain stable during induction, while lactate rises and central venous oxygen saturation drops.
- The model allows for controlled induction of varying degrees of cardio-circulatory impairment.
Conclusions
- This porcine model closely mimics clinical hemorrhagic shock and its pathophysiological effects on cerebral and systemic circulation.
- The approach enables detailed evaluation of therapeutic strategies such as fluid resuscitation, coagulation management, and catecholamine therapy.
- It provides a valuable platform for translational research into optimizing hemorrhagic shock treatment.
Frequently Asked Questions
What is the main advantage of this hemorrhagic shock model?
The model's main advantage is its flexibility and clinical relevance, allowing titration of shock severity based on real-time hemodynamic and cerebral oxygenation parameters rather than fixed blood volumes.
How is cerebral oxygenation monitored during the procedure?
Cerebral regional oxygenation is continuously monitored using near-infrared spectroscopy sensors placed on the pig's forehead, providing real-time feedback on cerebral hypoxia.
What hemodynamic parameters are assessed in this model?
Key parameters include cardiac index, mean arterial pressure, intrathoracic blood volume, global end-diastolic volume, stroke volume variation, and arterial blood pressure, measured via the PiCCO system.
How does this model improve upon traditional fixed-volume shock models?
Unlike fixed-volume models, this approach induces shock based on physiological endpoints, better reflecting the variability and complexity of clinical hemorrhagic shock.
What are the safety considerations when performing this protocol?
Strict aseptic technique, use of personal protective equipment, and careful monitoring are essential to prevent infection and manage the risk of sudden hemodynamic decompensation.
Can this model be used to test new therapies for hemorrhagic shock?
Yes, the model is designed to evaluate various therapeutic interventions, including fluid resuscitation, coagulation therapies, and catecholamine administration, in a controlled and clinically relevant setting.
What are the typical physiological changes observed during shock induction?
Typical changes include decreased cerebral oxygen saturation, reduced cardiac index, hypotension, tachycardia, increased lactate, and decreased central venous oxygen saturation.
Executive Industry Relevance
Standardized induction of hemorrhagic shock in a porcine model, guided by cerebral oximetry and advanced hemodynamic monitoring, enables precise simulation of clinically relevant circulatory failure. This approach supports translational research by providing reproducible, quantitative endpoints for evaluating therapeutic interventions targeting acute hypoxic injury. The model's flexibility and physiological fidelity enhance predictive confidence for preclinical assessment of shock therapies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of pathophysiological mechanisms underlying hemorrhagic shock and cerebral hypoxia.
- Supports functional validation of therapeutic targets involved in circulatory and oxygenation failure.
- Facilitates mechanistic de-risking by linking systemic and cerebral endpoints to intervention outcomes.
Screening & Assay Development
- Provides a validated, reproducible in vivo system for preclinical screening of resuscitation and shock therapies.
- Delivers quantitative hemodynamic and cerebral oxygenation readouts for assay standardization.
- Enables reliable comparison of candidate interventions under controlled, clinically relevant conditions.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints for translational biomarker development in acute care research.
- Ensures continuity from discovery through preclinical validation by modeling real-world shock scenarios.
- Supports risk-adjusted advancement of therapies targeting multi-organ hypoxic injury.
Pipeline & Workflow Integration
This model integrates into the preclinical discovery continuum, bridging early mechanistic studies and translational validation of shock interventions.
- Discovery Biology: Enables hypothesis testing on the interplay between systemic hemodynamics and cerebral oxygenation during shock.
- Screening: Provides reproducible, quantitative endpoints for evaluating intervention efficacy and safety.
- Analytics: Supports statistical comparison of hemodynamic and oxygenation parameters across experimental arms.
- Translational Research: Facilitates alignment with clinical endpoints relevant to acute care and trauma research.
- Enterprise Reuse: Offers a standardized platform adaptable for diverse therapeutic evaluation in hemorrhagic shock.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in shock therapy development.
- Operational Value: Enhances reproducibility, standardization, and scalability of preclinical shock studies.
- Strategic Value: Informs go/no-go decisions and optimizes resource allocation for acute care portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of candidates targeting hypoxic organ injury.
Implementation Considerations
- Requires expertise in advanced hemodynamic monitoring and cerebral oximetry instrumentation.
- Demands robust analytical infrastructure for real-time physiological data acquisition and interpretation.
- Necessitates cross-team standardization of procedural and analytical protocols.
- Adaptation may be needed for different animal models or intervention classes.
- Careful monitoring is essential to manage risks of sudden hemodynamic decompensation.
Biopharma FAQs
Why does null hypothesis testing matter for cerebral oximetry-guided shock induction?
Null hypothesis testing enables objective evaluation of whether observed changes in cerebral oxygenation and hemodynamic parameters are attributable to interventions or occur by chance, supporting robust target validation and mechanistic clarity in preclinical shock models.
How does independent variable isolation fit the hemodynamic monitoring workflow?
Isolating variables such as blood withdrawal volume or intervention timing allows precise attribution of physiological changes to specific experimental manipulations, enhancing interpretability and reproducibility in the discovery pipeline.
What do quantitative dependent variable measurements enable in this porcine model?
Quantitative tracking of cerebral oxygen saturation, cardiac index, and arterial pressure enables rigorous comparison of intervention effects, supports statistical analysis, and informs translational decision-making for candidate therapies.
Why are replication requirements critical for cross-functional hemorrhagic shock studies?
Replication ensures that observed physiological responses and intervention outcomes are consistent and generalizable, facilitating cross-team collaboration and confidence in advancing therapeutic candidates.
What statistical analysis capabilities are required before implementing shock induction protocols?
Robust statistical tools are needed to analyze hemodynamic and oxygenation data, assess significance of intervention effects, and support data-driven advancement decisions in preclinical R&D workflows.
Chapters in this video
0:04
Title
0:59
Instrumentation
2:45
Pulse Contour Cardiac Output (PiCCO) Measurement
3:54
Cerebral Regional Oxygenation Saturation
4:48
Hemorrhagic Shock Induction
5:52
Results: Representative Hemodynamic Parameter Evaluation During and After Hemorrhagic Shock
6:56
Conclusion
